- Home
- NIE vs TMCI Comparison
NIE vs TMCI Comparison
Compare NIE & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIE
- TMCI
- Stock Information
- Founded
- NIE 2007
- TMCI 2014
- Country
- NIE United States
- TMCI United States
- Employees
- NIE N/A
- TMCI N/A
- Industry
- NIE Investment Managers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NIE Finance
- TMCI Health Care
- Exchange
- NIE Nasdaq
- TMCI Nasdaq
- Market Cap
- NIE 697.4M
- TMCI 649.1M
- IPO Year
- NIE N/A
- TMCI 2021
- Fundamental
- Price
- NIE $24.54
- TMCI $9.37
- Analyst Decision
- NIE
- TMCI Hold
- Analyst Count
- NIE 0
- TMCI 8
- Target Price
- NIE N/A
- TMCI $8.84
- AVG Volume (30 Days)
- NIE 70.5K
- TMCI 413.1K
- Earning Date
- NIE 01-01-0001
- TMCI 02-27-2025
- Dividend Yield
- NIE 9.04%
- TMCI N/A
- EPS Growth
- NIE N/A
- TMCI N/A
- EPS
- NIE N/A
- TMCI N/A
- Revenue
- NIE N/A
- TMCI $202,861,000.00
- Revenue This Year
- NIE N/A
- TMCI $13.27
- Revenue Next Year
- NIE N/A
- TMCI $8.61
- P/E Ratio
- NIE N/A
- TMCI N/A
- Revenue Growth
- NIE N/A
- TMCI 16.14
- 52 Week Low
- NIE $18.61
- TMCI $3.92
- 52 Week High
- NIE $22.47
- TMCI $14.82
- Technical
- Relative Strength Index (RSI)
- NIE 43.98
- TMCI 47.42
- Support Level
- NIE $24.88
- TMCI $9.69
- Resistance Level
- NIE $25.20
- TMCI $10.30
- Average True Range (ATR)
- NIE 0.36
- TMCI 0.45
- MACD
- NIE -0.05
- TMCI -0.16
- Stochastic Oscillator
- NIE 13.98
- TMCI 3.40
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments such as aerospace and defense, banks, IT services, software, and others.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.